CHEST 2022 Coverage

 

CHEST 2022 Coverage
A

Rituximab in the Treatment of Idiopathic Inflammatory Myopathies With Interstitial Lung Disease: Long Term Follow Up

By CHEST 2022 Coverage FEATURING Anna Khelkovskaya-Sergeeva
By CHEST 2022 Coverage FEATURING Anna Khelkovskaya-Sergeeva
579 views
October 25, 2022
Comments 1
Login to view comments. Click here to Login
ILD
07:21

Outcomes in Patients With ILD Living in Economically Disadvantaged a…

CHEST 2022 Coverage

H. Kim

161 views
53:31

Approaching Sarcoidosis Therapy From a 21st Century Perspective

CHEST 2022 Coverage

D. Culver

7.0K views
11:22

Calcium Metabolism and Bones: Sarcoid Hypercalcemia, Kidney Disease …

CHEST 2022 Coverage

P. Sen

387 views
21:34

Management and Treatment Decisions in Progressive Pulmonary Fibrosis

CHEST 2022 Coverage

T. Kulkarni

4.8K views
24:02

Bronchoscopic Imaging for Interstitial Lung Disease

CHEST 2022 Coverage

G. Zhi Cheng

5.0K views
10:22

Rituximab in the Treatment of Idiopathic Inflammatory Myopathies Wit…

CHEST 2022 Coverage

A. Khelkovskaya-Sergeeva

579 views
19:21

A Radiologist's Approach to Subsolid Pulmonary Nodules

CHEST 2022 Coverage

A. Guttentag

5.3K views